These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 6366702)
1. [Place of hormone receptor determination in the therapeutic strategy of breast cancer]. Clavel B; Gest J Pathol Biol (Paris); 1983 Dec; 31(10):809-18. PubMed ID: 6366702 [TBL] [Abstract][Full Text] [Related]
2. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors]. Pouillart P; Madgelenat H; Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Polijcak M; Asselain B Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808 [TBL] [Abstract][Full Text] [Related]
3. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group. Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391 [TBL] [Abstract][Full Text] [Related]
4. The stability of estrogen and progesterone receptors in patients receiving preoperative chemotherapy for locally advanced breast carcinoma. Jain V; Landry M; Levine EA Am Surg; 1996 Feb; 62(2):162-5. PubMed ID: 8554195 [TBL] [Abstract][Full Text] [Related]
5. Steroid receptors in breast cancer. Desombre ER Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047 [TBL] [Abstract][Full Text] [Related]
6. Hormonal receptors and response to treatment of breast cancer: a retrospective evaluation in 60 patients. Loven D; Rakowsky E; Stein JA; Geier A; Lunenfeld B Isr J Med Sci; 1981; 17(9-10):960-4. PubMed ID: 7309485 [TBL] [Abstract][Full Text] [Related]
7. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer. Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K Anticancer Res; 1988; 8(4):647-51. PubMed ID: 2972248 [TBL] [Abstract][Full Text] [Related]
8. Hormone receptors and Japanese breast cancer. Matsumoto K; Kitamura Y; Sugano H Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994 [TBL] [Abstract][Full Text] [Related]
9. [Relation between estrogen and progesterone receptors and response to hormone therapy]. Leclercq G; Paridaens R; Heuson JC Pathol Biol (Paris); 1983 Dec; 31(10):793-800. PubMed ID: 6366700 [TBL] [Abstract][Full Text] [Related]
10. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction. Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476 [TBL] [Abstract][Full Text] [Related]
11. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays. Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B; J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359 [TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor status in breast cancer. Wright CJ Can J Surg; 1980 Jul; 23(4):316-7. PubMed ID: 7417890 [TBL] [Abstract][Full Text] [Related]
13. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. Cui X; Schiff R; Arpino G; Osborne CK; Lee AV J Clin Oncol; 2005 Oct; 23(30):7721-35. PubMed ID: 16234531 [TBL] [Abstract][Full Text] [Related]
14. [The criteria of the hormonal sensitivity of breast cancer]. Dryzhak VI Vopr Onkol; 1992; 38(2):166-73. PubMed ID: 1300701 [TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046 [TBL] [Abstract][Full Text] [Related]
16. Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease. Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Branković-Magić M; Kanjer K; Gavrilović D; Mitrović L; Borojević N; Vukotić D; Spuzić I J Exp Clin Cancer Res; 1999 Sep; 18(3):347-55. PubMed ID: 10606181 [TBL] [Abstract][Full Text] [Related]
17. Steroid hormone receptors in the management of human breast cancer. Knight WA; Osborne CK; Yochmowitz MG; McGuire WL Ann Clin Res; 1980 Oct; 12(5):202-7. PubMed ID: 7015982 [TBL] [Abstract][Full Text] [Related]
18. [Endocrine therapy of recurrent breast cancer]. Nomura Y; Tashiro H Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):421-7. PubMed ID: 3890756 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information. Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596 [TBL] [Abstract][Full Text] [Related]
20. The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis. Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ Cancer; 2006 Jun; 106(12):2576-82. PubMed ID: 16703595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]